
Azenta, Inc.
Azenta, Inc. (AZTA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AZTA · as of Jun 8, 2026
Key Statistics
Explore Azenta, Inc. Data
azta stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 12 · Buy rate: 58.3%
The AZTA analyst consensus is Buy, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month price target is $44.50, representing +96.12% upside from the current price of $22.69.
Competitors & Peers
azta competitorsStock Performance
Full HistoryAbout Azenta, Inc.
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates…
what is azenta, inc. · azta stock overview · azenta, inc. company profile · who is azenta, inc. ceo · azta NASDAQ · azenta, inc. headquarters · azenta, inc. business segments
About Stock Overview & Key Data
Azenta, Inc. (AZTA) is a Healthcare company in the Medical - Instruments & Supplies industry, listed on NASDAQ since Feb 2, 1995. As of the latest trading session, AZTA stock price is $22.69, with a market capitalization of $1.0B. The stock has returned -22.51% over the past 12 months and -31.78% year-to-date.
According to 12 Wall Street analysts, the consensus rating for Azenta, Inc. stock is Buy, with an average 12-month price target of $44.50. In fiscal year 2025, Azenta, Inc. reported revenue of $593.8M and net income of -$55.8M. For detailed data — including Azenta, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Azenta, Inc. (AZTA) stock price is $22.69. The stock is traded on NASDAQ under the ticker symbol AZTA. The 52-week range is $15.93 – $41.73.